Social determinants of health and inequalities in COVID-19
doi: 10.1136/heartjnl-2021-320054 48 UfnalMZadloAOstaszewskiR
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R
For instance, a large network meta-analysis showed that SGLT-2 inhibitors reduced hospitalization for HF and renal composite outcome more than GLP-1RA [15], and that in patients with cardiovascular disease, SGLT-2 inhibitors show significant reduction in both heart failure (HF) hospitalizations and mortality for patients with HF and reduced ejection fraction [16]
But in this corner of the Internet, all claims are fully examined using the latest scientific evidence and experiential knowledge accumulated over decades
This makes cagrilintide particularly relevant in research models focused on body composition and fat-mass regulation rather than simple changes in scale weight alone